One of the largest markets in the Middle East & Africa (MEA) region, similar in size to Iran. Market size is supported by a large population and Africa's most industrialised economy. Owing to the size of the population, per capita spending is low. Spending on medical devices as a proportion of wealth is below average for the MEA region. Other medical devices accounts for nearly 40% of the total market. Underdeveloped market offers considerable potential for growth but currently constrained by funding issues, poor infrastructure and staff shortages. National Health Insurance programme in the early stages of implementation, but question marks remain on funding and delivery of key targets. Limited medical device production, therefore market largely dependent on imports.

Second largest market in the CEE region. Per capita spending is below the CEE average. Slowest market growth in the CEE region, in US dollar terms. Other medical devices and consumables have the largest market shares.The market remains heavily reliant on imports. Turkey has a large number of manufacturers, but these tend to be small-scale, concentrating on cheap, low-technology items. In recent years, Turkey has focused on developing its healthcare system, with the goal of providing universal healthcare, although this is yet to be achieved. Over three quarters of total health expenditure comes from the public sector, primarily central & local governments and social security programmes.

There are two types of batteries including primary and secondary. Primary batteries are the one that can be used only once whereas secondary batteries can be charged and reused. Various batteries include lead acid, nickel cadmium, lithium ion, nickel metal hydride, and alkaline.

The scope of the report is limited to the revenue generated from the sales of nuclear imaging systems, also known as nuclear medicine equipment, which include SPECT and PET. SPECT and PET can be further subcategorized as standalone and hybrid systems. The standalone equipment work independently, whereas two technologies, such as PET and computed tomography (CT) or SPECT and CT, are used together for better outcomes and are known as hybrid PET and hybrid SPECT, respectively.

Third smallest market in the Asia Pacific (APAC) region. Per capita spending is one of the lowest in the world. Market will record double-digit growth over the next five years in local currency terms. Other medical devices and consumables have the largest market shares. The market is heavily reliant on imports. Domestic manufacturing is concentrated in Sialkot and centres mainly around steel surgical instruments and other hand held medical devices. Production is of a high quality but mostly destined for export.

Small but sophisticated medical device market.  Imports supply most of the market.  Other medical devices and diagnostic imaging have the largest market shares.  High per capita spending in the Middle East Africa region.  High single-digit market CAGR driven by the National Health Strategy.

Theranostics is the merger between diagnostics and therapeutics as a test required for selection of patient sub-population for clinical trials or predicting responsiveness of a patient to a given drug. It covers the path for personalized medicine by involving the utilization of molecular assays for determination of dosage for the concerned patient at a given point of time. Theranostics or pharmacodiagnostics tests are applicable in the determination of drug efficacy, drug selection, risk of recurrence, and diseases progression & predisposition, dose designing. The aforementioned applications are implemented in the management of several diseases such as cancers, neurological disorders, cardiovascular diseases, immunological disorders, cardiovascular diseases, and in diverse infectious diseases.

Largest medical device market in the Central & Eastern Europe (CEE) region.  Per capita spending is low for the CEE region.  Market will record high single-digit growth in local currency terms. Other medical devices and diagnostic imaging have the largest market shares. The government has increased the number of medical devices subject to import restrictions, which could negatively impact the sales of foreign manufacturers. Import shares may fall by 2020, in accordance with the Ministry of Industry and Trade's import substitution plan, which aims to reduce the import shares of 111 groups of medical devices. The greatest opportunities exist around the major cities of Moscow and St Petersburg, where most companies are based and per capita incomes are well above the national average.

Silicon carbide (SiC) power semiconductor is a power device, which is used to control the distribution of power in an electronics system. The wider band gap, high switching frequency, and high electric field strength of SiC power devices allow them to be operated at higher temperatures and volumes as compared to their silicon counterparts. the silicon carbide power devices market has witnessed significant growth, owing to increasing number of industrial sectors that require SiC power devices such as manufacturing, automotive, and energy & power sectors.

Sixth smallest market in the CEE region. Per capita spending is well above regional average. Market will record a mid single-digit US dollar CAGR. Other medical devices and consumables have the largest market shares. Most requirements are imported, largely from other EU countries. Local production of basic items is strong but geared to exports. Comprehensive public health insurance system. Relatively robust private health insurance sector. Slovenia has long had a good reputation in specialist areas such as dentistry, attracting patients from neighbouring countries.